ES2111013T3 - Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica. - Google Patents

Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.

Info

Publication number
ES2111013T3
ES2111013T3 ES92109970T ES92109970T ES2111013T3 ES 2111013 T3 ES2111013 T3 ES 2111013T3 ES 92109970 T ES92109970 T ES 92109970T ES 92109970 T ES92109970 T ES 92109970T ES 2111013 T3 ES2111013 T3 ES 2111013T3
Authority
ES
Spain
Prior art keywords
ws7622a
prophylactic
chronic
respiratory tract
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92109970T
Other languages
English (en)
Inventor
Noriaki Inamura
Yasuhiko Shingu
Kunio Nakahara
Yoshitada Notsu
Masanori Okamoto
Shigehiro Takase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3245283A external-priority patent/JP2663763B2/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2111013T3 publication Critical patent/ES2111013T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UNA COMPOSICION PROFILACTICA/TERAPEUTICA PARA LA COAGULACION INTRAVASCULAR DISEMINADA, ENFERMEDADES INFECCIOSAS DE LAS VIAS RESPIRATORIAS CRONICAS O LA BRONQUITIS CRONICA QUE CONTIENE UN ESTER DE MONO O DISULFATO DE WS7322A O SUS SALES FARMACEUTICAMENTE ACEPTABLES. AL WS7622A SE LE CONOCE DE LA SOLICITUD DE PATENTE EUROPEA 91110243.2 (EP-A-0 465 895).
ES92109970T 1991-06-18 1992-06-13 Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica. Expired - Lifetime ES2111013T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3245283A JP2663763B2 (ja) 1990-06-29 1991-06-18 Ｗｓ７６２２ａジ硫酸エステル、その製造法およびその用途
JP36113591 1991-12-19

Publications (1)

Publication Number Publication Date
ES2111013T3 true ES2111013T3 (es) 1998-03-01

Family

ID=26537148

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92109970T Expired - Lifetime ES2111013T3 (es) 1991-06-18 1992-06-13 Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.

Country Status (8)

Country Link
US (1) US5279826A (es)
EP (1) EP0519354B1 (es)
AT (1) ATE161016T1 (es)
CA (1) CA2071425C (es)
DE (1) DE69223455T2 (es)
DK (1) DK0519354T3 (es)
ES (1) ES2111013T3 (es)
GR (1) GR3025656T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2421505T3 (es) * 1998-02-24 2013-09-03 Astellas Pharma Inc Preventivos/remedios contra el envejecimiento de la piel
ATE374026T1 (de) * 1999-03-25 2007-10-15 Mitsubishi Pharma Corp Rho-kinase-inhibitoren für die vorbeugung oder behandlung von interstitieller pneumonie und pulmonaler fibrose
AU6870800A (en) 1999-09-06 2001-04-10 Ono Pharmaceutical Co. Ltd. Preventive and therapeutic agents for eye diseases
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same
GB9014546D0 (en) * 1990-06-29 1990-08-22 Fujisawa Pharmaceutical Co Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Also Published As

Publication number Publication date
CA2071425C (en) 1997-02-04
EP0519354B1 (en) 1997-12-10
EP0519354A1 (en) 1992-12-23
DE69223455T2 (de) 1998-04-02
US5279826A (en) 1994-01-18
CA2071425A1 (en) 1992-12-19
GR3025656T3 (en) 1998-03-31
DK0519354T3 (da) 1998-01-12
ATE161016T1 (de) 1997-12-15
DE69223455D1 (de) 1998-01-22

Similar Documents

Publication Publication Date Title
BR9611015A (pt) Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto
ES2196303T3 (es) Administracion de nicotina por el colon para tratar enfermedades intestinales inflamatorias.
ES2186787T3 (es) Utilizacion de ritonavir (abt-538) para mejorar la farmacocinetica de medicamentos metabolizados por el citocromo p450 en un metodo de tratamiento del sida.
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
LU91541I2 (fr) latanoprost et ses dérivés pharmaceutiquement acceptables (XALATAN)
MD950086A (ro) Utilizare a analogilor nucleozidici ai 1,3-oxatiolanei in tratamentul hepatitei B Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis B
AR021226A1 (es) Terapia combinatoria con ribavirina-interferon alfa para erradicar el hcv-rna detectable en aquellos pacientes que presentan infeccion porhepatitis c cronica
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
PT1098643E (pt) Fenilacetilglutamina fenilacetilisoglutamina e/ou fenilacetato para o tratamento de doencas neoplasicas
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0796103T3 (da) Anvendelse af røgelse til behandling af Alzheimer-sygdommen
MD306B1 (ro) Remediu pentru profilaxia afectiunilor vasculare determinate de actiunea peroxizilor glicoproteinfixati
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
ES2111013T3 (es) Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
ATE82294T1 (de) Therapeutische nukleoside.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ATE360428T1 (de) Analgetisches arzneimittel
DK0784475T3 (da) Prostaglandinanaloger til oral eller vaginal indgivelse til rutinemæssig behandling af fødslens tredje trin
ES2115571T3 (es) Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
HUP9800810A2 (hu) Kombinációs terápia emberi immunhiány-vírusos (HIV) ferőzés kezelésére
HUP9801686A2 (hu) Amino-tetralin-származék alkalmazása kardiovaszkuláris megbetegedések terápiájában használható gyógyszer előállítására
MX9305887A (es) Uso de acido hialuronico y formas para evitar restenosis arterial.
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 519354

Country of ref document: ES